| 000 | 01837 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518015036.0 | ||
| 264 | 0 | _c20200724 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1476-5640 | ||
| 024 | 7 |
_a10.1038/s41430-018-0382-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaadati, Saeede | |
| 245 | 0 | 0 |
_aThe effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical nutrition _c03 2019 |
||
| 300 |
_a441-449 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHomeostasis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 | _aIran |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xblood |
| 700 | 1 | _aHatami, Behzad | |
| 700 | 1 | _aYari, Zahra | |
| 700 | 1 | _aShahrbaf, Mohammad Amin | |
| 700 | 1 | _aEghtesad, Sareh | |
| 700 | 1 | _aMansour, Asieh | |
| 700 | 1 | _aPoustchi, Hossein | |
| 700 | 1 | _aHedayati, Mehdi | |
| 700 | 1 | _aAghajanpoor-Pasha, Morteza | |
| 700 | 1 | _aSadeghi, Amir | |
| 700 | 1 | _aHekmatdoost, Azita | |
| 773 | 0 |
_tEuropean journal of clinical nutrition _gvol. 73 _gno. 3 _gp. 441-449 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41430-018-0382-9 _zAvailable from publisher's website |
| 999 |
_c29221806 _d29221806 |
||